CYTOSORBENTS CORPORATION (CTSO) Gross margin 2016–2025
CYTOSORBENTS CORPORATION (CTSO) gross margin by fiscal year — reported gross profit divided by reported revenue.
71.5%FY2025 · since FY2016: 58.5% → 71.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 71.5% | +1.6 pp |
| FY2024 | 69.9% | -0.7 pp |
| FY2023 | 70.6% | +10.9 pp |
| FY2022 | 59.8% | -14.6 pp |
| FY2021 | 74.4% | +1.4 pp |
| FY2020 | 73.0% | +2.6 pp |
| FY2019 | 70.5% | +3.8 pp |
| FY2018 | 66.7% | +3.1 pp |
| FY2017 | 63.6% | +5.1 pp |
| FY2016 | 58.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice